2021
Distribution of the workforce involved in cancer care: a systematic review of the literature ☆
Trapani D, Murthy S, Boniol M, Booth C, Simensen V, Kasumba M, Giuliani R, Curigliano G, Ilbawi A. Distribution of the workforce involved in cancer care: a systematic review of the literature ☆. ESMO Open 2021, 6: 100292. PMID: 34763251, PMCID: PMC8591344, DOI: 10.1016/j.esmoop.2021.100292.Peer-Reviewed Original ResearchConceptsCancer careSystematic reviewHigh-income countriesHealth providersMultidisciplinary cancer careMultidisciplinary cancer managementSkilled health workforceCross-sectional surveyPaucity of dataHealth care workforcePaucity of literatureFirst systematic reviewCancer nursesCancer patientsPediatric oncologySurgical oncologyHealth workersWorkforce densityCancer managementEligible papersCancer workforceHealth workforceHealth systemCare workforceWorkforce capacity
2018
Systematic review of the real‐world evidence of adalimumab safety in psoriasis registries
Strober B, Crowley J, Langley R, Gordon K, Menter A, Leonardi C, Arikan D, Valdecantos W. Systematic review of the real‐world evidence of adalimumab safety in psoriasis registries. Journal Of The European Academy Of Dermatology And Venereology 2018, 32: 2126-2133. PMID: 30067882, DOI: 10.1111/jdv.15203.Peer-Reviewed Original ResearchConceptsMajor cardiac eventsAdverse eventsPsoriasis RegistryReal-world evidenceAdalimumab safetySerious AEsAdult patientsCardiac eventsClinical studiesSafety dataLong-term safety profileCardiovascular-related eventsSerious adverse eventsSerious cardiovascular eventsReal-world safetyLong-term safetyRate of infectionEnglish language manuscriptsCardiovascular eventsSafety profileSerious infectionsAdalimumabClinical practiceEligible papersRegistry
2014
Modeling of Novel Diagnostic Strategies for Active Tuberculosis – A Systematic Review: Current Practices and Recommendations
Zwerling A, White RG, Vassall A, Cohen T, Dowdy DW, Houben RM. Modeling of Novel Diagnostic Strategies for Active Tuberculosis – A Systematic Review: Current Practices and Recommendations. PLOS ONE 2014, 9: e110558. PMID: 25340701, PMCID: PMC4207742, DOI: 10.1371/journal.pone.0110558.Peer-Reviewed Original ResearchConceptsNucleic acid amplification testsIncremental cost-effectiveness ratioActive tuberculosisHealth system modelDiagnostic strategiesNovel diagnostic strategiesAlternative nucleic acid amplification testsXpert MTB/RIFMTB/RIFCost-effectiveness ratioMulti-way sensitivity analysesFalse-negative diagnosesPre-diagnostic periodCost-effectiveness modelCost-effectiveness estimatesDiagnostic delayDiagnostic pathwayAdditional epidemiological dataTB diagnosticsEpidemiological dataReference listsAmplification testsEpidemiological impactEligible papersEpidemiological settings
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply